Standout Papers
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2010)
- Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials (1999)
- Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers (2015)
Immediate Impact
4 by Nobel laureates 12 from Science/Nature 82 standout
Citing Papers
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
2023 Standout
Works of Eric T. Wong being referenced
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
2018
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eric T. Wong | 4744 | 2299 | 1390 | 1910 | 145 | 8.0k | |
| William R. Shapiro | 4611 | 2795 | 1697 | 1425 | 136 | 8.8k | |
| Ian F. Parney | 4202 | 2178 | 2603 | 1438 | 195 | 9.1k | |
| Michael Sabel | 6419 | 2462 | 854 | 2539 | 182 | 9.1k | |
| Griffith R. Harsh | 3114 | 2278 | 1495 | 1851 | 114 | 8.2k | |
| S. Clifford Schold | 5938 | 2485 | 1732 | 1673 | 112 | 9.6k | |
| Randy L. Jensen | 3677 | 1568 | 1294 | 938 | 202 | 7.4k | |
| Steven Brem | 2785 | 1295 | 1449 | 1240 | 190 | 7.5k | |
| Ryo Nishikawa | 4172 | 1648 | 2071 | 929 | 198 | 8.3k | |
| Andrew B. Lassman | 5632 | 2922 | 2059 | 1997 | 190 | 8.5k | |
| Stephen W. Coons | 3364 | 1210 | 642 | 1430 | 147 | 6.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...